Journament

Keyword Connections - brca1 Keywords

Connection Type	Connection
Journals	Cancers The Cochrane database of systematic reviews Journal of the history of the behavioral sciences Nursing standard (Royal College of Nursing (Great Britain) : 1987) Journal of education and health promotion Acta neurochirurgica The National medical journal of India Molecular oncology Developmental cell Regenerative medicine Drug information journal
Research Groups	No Research Group Connected
Bibliographies	[1] the endonuclease eepd1 mediates synthetic lethality in rad52-depleted brca1 mutant breast cancer cells [2] the expression of ercc1 and brca1 predicts prognosis of platinum-based chemotherapy in urothelial cancer [3] the igf hormonal network in endometrial cancer: functions, regulation and targeting approaches [4] brca1 reversion mutation acquired after treatment identified by liquid biopsy [5] brca1 and brca2 mutations in iranian breast cancer patients: a systematic review [6] A human breast atlas integrating single-cell proteomics and transcriptomics. [7] Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms. [8] World Conference on Regenerative Medicine. [9] Patient satisfaction after surgery for trigeminal neuralgia--development of a questionnaire. [10] Sidelines. [11] Medical writing some cues and clues from a medical copywriter. [12] The medical copywriter in the pharmaceutical industry: an uphill climb after a downhill slide. [13] The concept of suggestion in the early history of advertising psychology. [14] BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer. [15] Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers [16] Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors. [17] Bioinformatics and Molecular Analysis of the Breast Cancer Susceptibility Gene BRCA1 in Breast Cancer [18] Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition. [19] BRCA1 and S phase DNA repair pathways restrict LINE-1 retrotransposition in human cells. [20] RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence [21] [Cáncer de mama en seis familias del Tolima y el Huila: mutación BRCA1 3450del4]. [22] brca1 1675dela and 1135insa account for one third of norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations [23] the endonuclease eepd1 mediates synthetic lethality in rad52-depleted brca1 mutant breast cancer cells [24] brca1 mutation- oncological treatment- reconstructive surgery of the breast- pregnancy: diagnostic and therapeutic procedures in a 28 year old patient diagnosed with a tumor in the left breast with a brca1 mutation [25] brca1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of c-terminal binding protein 2 [26] primary peritoneal carcinoma in a brca1/2-negative, palb2-positive patient [27] the expression of ercc1 and brca1 predicts prognosis of platinum-based chemotherapy in urothelial cancer [28] a mammary-specific, long-range deletion on mouse chromosome 11 accelerates brca1-associated mammary tumorigenesis [29] brca1 reversion mutation acquired after treatment identified by liquid biopsy [30] contribution of brca1 and brca2 germline mutations to early algerian breast cancer [31] the spectrum of the most common brca1/brca2 mutations in lithuanian high risk families [32] high resolution melting (hrm) analysis for genetic changes in brca1/2 gene [33] the occurrence and contribution of germline brca1/2 sequence alterations in iranian patients with breast cancer [34] the use of sentinel lymph node biopsy in brca1/2 mutation carriers undergoing prophylactic mastectomy: a retrospective consecutive case-series study [35] brca1 forms a functional complex with γ-h2ax as a late response to genotoxic stress [36] brca1 and brca2 mutations in iranian breast cancer patients: a systematic review [37] BRCA1 deficiency in skin epidermis leads to selective loss of hair follicle stem cells and their progeny [38] BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancer - Oncogenesis [39] BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancer. [40] BRCA1/BARD1 inhibition of mRNA 3′ processing involves targeted degradation of RNA polymerase II [41] Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms.